BioGaia AB (OSTO:BIOG B) 3-Year Share Buyback Ratio : -0.10% (As of Jun. 2025)

View and export this data going back to 1998. Start your Free Trial

What is BioGaia AB 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. BioGaia AB's current 3-Year Share Buyback Ratio was -0.10%.

The historical rank and industry rank for BioGaia AB's 3-Year Share Buyback Ratio or its related term are showing as below:

OSTO:BIOG B' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -5.2 Med: -0.1 Max: 0.1
Current: -0.1

During the past 13 years, BioGaia AB's highest 3-Year Share Buyback Ratio was 0.10%. The lowest was -5.20%. And the median was -0.10%.

OSTO:BIOG B's 3-Year Share Buyback Ratio is ranked better than
73.86% of 677 companies
in the Drug Manufacturers industry
Industry Median: -2.2 vs OSTO:BIOG B: -0.10

Competitive Comparison of BioGaia AB's 3-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGaia AB's 3-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

BioGaia AB 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

BioGaia AB (OSTO:BIOG B) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

BioGaia AB 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of BioGaia AB's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OSTO:BIOG B) » Definitions » 3-Year Share Buyback Ratio

Traded in Other Exchanges

BIOGY:USA BIOGBs:UK 0GTN:UK BGLA:Germany BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

No Headlines